Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that understanding the anatomical changes of the ageing face is important for effective rejuvenation treatments.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Using neurohormones to control keratin can lead to new skin disease treatments.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Annurca apple extract promotes hair growth by changing hair follicle metabolism to boost keratin production.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Non-obese women with hair loss have higher heart disease risk.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.